American Diabetes Association 2026 Scientific Sessions
A key challenge in studying native GLP-1 is its extremely short in vivo half-life of approximately 12 minutes, owing to rapid inactivation by dipeptidyl peptidase-4 (DPP-4), which cleaves the N-terminal His-Ala dipeptide from GLP-1 to produce the inactive metabolite GLP-1(936)amide
How to verify an online pharmacy is legitimate Whether you're buying brand-name or considering any kind of compounded medication, the basic safety check is the same
Retatrutide is an investigational triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors currently being studied as an investigational medicine for obesity and type 2 diabetes (phase 2 data published in the New England Journal of Medicine, 2023)
Rising Prevalence of Type 2 Diabetes Globally Consumption of highly processed food containing refined sugars and unhealthy fats is causing more people to develop type 2 diabetes
Minimizing Side Effects One of the most frequently cited reasons for microdosing GLP-1 drugs, as mentioned above, is the desire to minimize side effects
